Frederick R. Vogel - Concepedia

Author

Frederick R. Vogel

Also Known As

F R Vogel, F Vogel, F. R. Vogel, F. Vogel, F.R. Vogel, FREDERICK R. VOGEL, Frederick R Vogel, Frederick R. Vogel, Frederick Vogel, Vogel, F. R.

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Sanofi (France)University of Bergen National Institute of Allergy and Infectious Diseases National Institute for Biological Standards and Control Institut Pasteur

About

Frederick R. Vogel is an author at Sanofi (France) specializing in immunology, medicine, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	496
2	Immunology	10	10	496
3	Allergy	4	4	148
4	Education	1	1	14
5	Behavioral Sciences	1	1	60

Frederick R. Vogel

Publications

722

Citations

H-Index

Page 1

	Year	Citations
A phase I clinical trial of a PER.C6® cell grown influenza H7 virus vaccine Rebecca Jane Cox, Abdullah S. Madhun, Solveig Hauge, Vaccine VaccinationVaccine DevelopmentImmunologyVirologyInfluenza Vaccine	2009	140
Adsorption to aluminum hydroxide promotes the activity of IL-12 as an adjuvant for antibody as well as type 1 cytokine responses to HIV-1 gp120 Dragana Janković, Patricia Caspar, M Zweig, The Journal of Immunology	1997	96
Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase Cheguo Tsai, Catherine Caillet, Hongxing Hu, Vaccine VaccinationVeterinary VaccineViral EvolutionH5n1 CladesImmunology	2009	60
Adjuvants in perspective. Frederick R. Vogel PubMed VaccinationMucosal VaccinationBehavioral SciencesAllergyVaccine Antigens	1998	60
Cryptococcal capsular polysaccharide-induced modulation of murine immune responses J. Breen, I C Lee, Frederick R. Vogel, Infection and Immunity InflammationMucosal VaccinationAllergyMedicineHumoral Response	1982	51
AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice Catherine Caillet, Fabienne Piras, Marie‐Clotilde Bernard, Vaccine VaccinationCross-protectionStrong Antibody ResponsesVaccine DevelopmentUnprimed Mice	2010	51
Deficiency of HIF1α in Antigen-Presenting Cells Aggravates Atherosclerosis and Type 1 T-Helper Cell Responses in Mice Sweena M. Chaudhari, Judith C. Sluimer, Miriam Koch, Arteriosclerosis Thrombosis and Vascular Biology	2015	50
Heterosubtype Neutralizing Responses to Influenza A (H5N1) Viruses Are Mediated by Antibodies to Virus Haemagglutinin Jean‐Michel Garcia, Stéphanie Pépin, Nadège Lagarde, PLoS ONE	2009	46
Epitopic suppression in synthetic vaccine models: Analysis of the effector mechanisms M.P. Schutze, Claude Leclerc, Frederick R. Vogel, Cellular Immunology VaccinationCross-protectionEffector MechanismsVaccine DevelopmentMedicine	1987	45
A cell‐based H7N1 split influenza virion vaccine confers protection in mouse and ferret challenge models Rebecca Jane Cox, Diane Major, Solveig Hauge, Influenza and Other Respiratory Viruses	2009	34

Page 1